Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.

Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.
复制标题

DOI:
10.1038/onc.2012.561
复制
发表时间:
2014-01-02
期刊:
影响因子:
8
通讯作者:
Larner JM
Larner JM
中科院分区:
医学1区
文献类型:
--
作者:
Sarkar S;Brautigan DL;Parsons SJ;Larner JM

文献摘要

被引文献

相似文献

雄激素受体(AR)通过促进G1-S进展在前列腺癌的发生和发展中起重要作用,可能通过作为DNA复制的许可因子发挥作用。我们报道了小剂量2-甲氧基雌二醇(2-ME),一种内源性雌激素代谢产物,通过激活E3连接酶芯片(Hsp70相互作用蛋白的C末端)和AR的降解而诱导前列腺癌细胞有丝分裂停止。通过小干扰RNA(SiRNA)耗尽AR可以消除2-ME诱导的细胞分裂停滞,而将AR引入PC3-M细胞可以实现2-ME诱导的有丝分裂停滞。单独或联合敲除CHIP或MDM2(小鼠双分钟2蛋白同源物)可减少2-ME引起的AR降解和M期停滞。我们的数据将泛素化导致的AR退化与有丝分裂停滞联系在一起。通过激活E3连接酶如CHIP靶向AR代表了前列腺癌治疗的一种新策略。
The androgen receptor (AR) has a vital role in the onset and progression of prostate cancer by promoting G1-S progression, possibly by functioning as a licensing factor for DNA replication. We here report that low dose 2-methoxyestradiol (2-ME), an endogenous estrogen metabolite, induces mitotic arrest in prostate cancer cells involving activation of the E3 ligase CHIP (C-terminus of Hsp70-interacting protein) and degradation of the AR. Depletion of the AR by small interfering RNA (siRNA) eliminates 2-ME-induced arrest and introducing AR into PC3-M cells confers 2-ME-induced mitotic arrest. Knockdown of CHIP or MDM2 (mouse homolog of double minute 2 protein) individually or in combination reduced AR degradation and abrogated M phase arrest induced by 2-ME. Our data link AR degradation via ubiquitination to mitotic arrest. Targeting the AR by activating E3 ligases such as CHIP represents a novel strategy for the treatment of prostate cancer.